137 related articles for article (PubMed ID: 7459239)
21. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.
Alkner S; Ehinger A; Bendahl PO; Rydén L; Fernö M
Eur J Cancer; 2015 Nov; 51(16):2304-13. PubMed ID: 26243193
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptors and breast cancer.
Nicholson RI; Griffiths K; Blamey RW; Bishop HM; Haybittle JL
Environ Health Perspect; 1981 Apr; 38():143-6. PubMed ID: 7238443
[TBL] [Abstract][Full Text] [Related]
23. Oestrogen-receptor status and sites of metastasis in breast cancer.
Campbell FC; Blamey RW; Elston CW; Nicholson RI; Griffiths K; Haybittle JL
Br J Cancer; 1981 Sep; 44(3):456-9. PubMed ID: 7284240
[TBL] [Abstract][Full Text] [Related]
24. Variations in steroid receptor status with disease stage in breast cancer.
Stebbings WS; Anderson E; Puddefoot JR; Vinson GP; Gilmore OJ; Plowman PN
Eur J Surg Oncol; 1989 Aug; 15(4):322-7. PubMed ID: 2759250
[TBL] [Abstract][Full Text] [Related]
25. Effects of endocrine therapy on steroid-receptor content of breast cancer.
Taylor RE; Powles TJ; Humphreys J; Bettelheim R; Dowsett M; Casey AJ; Neville AM; Coombes RC
Br J Cancer; 1982 Jan; 45(1):80-5. PubMed ID: 6277358
[TBL] [Abstract][Full Text] [Related]
26. Steroid receptors in breast cancer.
Desombre ER
Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
[TBL] [Abstract][Full Text] [Related]
27. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
[TBL] [Abstract][Full Text] [Related]
28. The clinical value of multiple steroid receptor assays in breast cancer management.
Skinner LG; Barnes DM; Ribeiro GG
Cancer; 1980 Dec; 46(12 Suppl):2939-45. PubMed ID: 7448741
[TBL] [Abstract][Full Text] [Related]
29. Soluble and nuclear oestrogen receptor status of advanced endometrial cancer in relation to subsequent clinical prognosis.
Castagnetta L; Lo Casto M; Granata OM; Calabro M; Ciaccio M; Leake RE
Br J Cancer; 1987 May; 55(5):543-6. PubMed ID: 3606946
[TBL] [Abstract][Full Text] [Related]
30. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
[TBL] [Abstract][Full Text] [Related]
31. Tamoxifen therapy, oestrogen receptor status, and postmenopausal breast cancer.
A'Hern RP; Wilson AJ; Baum M
Lancet; 1985 Apr; 1(8435):976. PubMed ID: 2859424
[No Abstract] [Full Text] [Related]
32. Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.
Skinner JR; Wanebo HJ; Betsill WL; Wilhelm MC; Drake CR; Macleod RM
Ann Surg; 1982 Dec; 196(6):636-41. PubMed ID: 7149814
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor determination in percutaneous bone marrow biopsies of patients with metastatic breast cancer.
Wortman JE; Rundles RW; Moore JO; McCarty KS; McCarty KS
Med Pediatr Oncol; 1979; 7(3):277-83. PubMed ID: 542192
[TBL] [Abstract][Full Text] [Related]
34. Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle.
Markopoulos C; Berger U; Wilson P; Gazet JC; Coombes RC
Br Med J (Clin Res Ed); 1988 May; 296(6633):1349-51. PubMed ID: 3134982
[TBL] [Abstract][Full Text] [Related]
35. [Nuclear receptors in estrogen receptor negative tumors with progesterone receptors].
Geyer H; Braun A
Onkologie; 1987 Apr; 10(2):79-82. PubMed ID: 3295630
[TBL] [Abstract][Full Text] [Related]
36. Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients.
Shek LL; Godolphin W; Spinelli JJ
Br J Cancer; 1987 Dec; 56(6):825-9. PubMed ID: 3435707
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
[TBL] [Abstract][Full Text] [Related]
38. [Relation of steroid hormone receptors to axillary lymph node metastasis in breast carcinoma].
Etzrodt A; Jung H; Schweissfurth C; Tolxdorff T; Lamberti G
Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):726-31. PubMed ID: 6559147
[TBL] [Abstract][Full Text] [Related]
39. PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
Gion M; Mione R; Pappagallo GL; Gatti C; Nascimben O; Bari M; Leon AE; Vinante O; Bruscagnin G
Br J Cancer; 1993 Aug; 68(2):374-9. PubMed ID: 8347494
[TBL] [Abstract][Full Text] [Related]
40. Oestrogen and progesterone receptor determinations in breast cancer: technology and biology.
Thorpe SM; Rose C
Cancer Surv; 1986; 5(3):505-25. PubMed ID: 3555780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
